Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Apoptosis
    (50)
  • Autophagy
    (41)
  • 5-HT Receptor
    (21)
  • CDK
    (20)
  • PI3K
    (18)
  • HDAC
    (17)
  • Epigenetic Reader Domain
    (15)
  • mTOR
    (14)
  • EGFR
    (12)
  • Others
    (443)
Filter
Search Result
Results for "

selectivity

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    1024
    TargetMol | Inhibitors_Agonists
  • Compound Libraries
    5
    TargetMol | Compound_Libraries
  • Peptide Products
    70
    TargetMol | Peptide_Products
  • Inhibitory Antibodies
    1
    TargetMol | Inhibitory_Antibodies
  • Dye Reagents
    31
    TargetMol | Dye_Reagents
  • PROTAC Products
    14
    TargetMol | PROTAC
  • Natural Products
    22
    TargetMol | Natural_Products
  • Recombinant Protein
    3
    TargetMol | Recombinant_Protein
  • Isotope Products
    6
    TargetMol | Isotope_Products
  • Disease Modeling
    3
    TargetMol | Disease_Modeling_Products
Escitalopram
Seroplex, S-(+)-Citalopram, (S)-Citalopram
T0185128196-01-0
Escitalopram (Seroplex) is a furancarbonitrile that is one of the SEROTONIN UPTAKE INHIBITORS used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from tardive dyskinesia in preference to tricyclic antidepressants, which aggravate this condition.
  • Inquiry Price
1-2 weeks
Size
QTY
TargetMol | Citations Cited
pde9-in-(s)-c33
T283522066488-39-7
PDE9-IN-(S)-C33 ((S)-C33) is a potent and selective inhibitor of PDE9 (IC50 = 11 nM). PDE9-IN-(S)-C33 can be used for central nervous system diseases and diabetes research.
  • Inquiry Price
8-10 weeks
Size
QTY
TargetMol | Inhibitor Sale
stafia-1
T93392582757-90-0
Stafia-1 is a potent STAT5a inhibitor (IC50=22.2 μM), displaying high selectivity over STAT5b and other STAT family members.
  • Inquiry Price
Size
QTY
PX-478
T6961685898-44-6
PX-478 is a HIF-1α inhibitor with selectivity, oral activity, and blood-brain barrier permeability. PX-478 has antitumor activity and also protects pancreatic β-cell function in diabetes mellitus and is used in type 2 diabetes mellitus research.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
R-7050
TNF-α Antagonist III
T4637303997-35-5
R-7050 (TNF-α Antagonist III) is a tumor necrosis factor receptor (TNFR) antagonist that exhibits heightened selectivity for TNFα.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Semaxinib
SU5416
T2064204005-46-9
Semaxinib (SU5416) is a potent and selective VEGFR2 inhibitor (IC50: 1.23 μM), exhibiting a 20-fold greater selectivity for VEGFR2 over PDGFRβ, with no activity against InsR, EGFR, and FGFR. Semaxinib reversibly inhibits ATP binding to the tyrosine kinase domain of VEGFR2, potentially inhibiting VEGF-stimulated endothelial cell migration and proliferation, thereby reducing tumor microvasculature.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
PLX5622
PLX-5622
T71001303420-67-8
PLX5622 is a highly selective, brain-penetrant, and orally active CSF1R inhibitor.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
JNK-IN-8
JNK Inhibitor XVI
T26681410880-22-6
JNK-IN-8 (JNK Inhibitor XVI) is an irreversible JNK1 2 4 inhibitor (IC50: 4.7 18.7 1 nM) with over 10-fold selectivity compared to MNK2 and Fms, and no inhibition of Met, c-Kit, or PDGFRβ in the A375 cell line.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
GW9662
TIMTEC-BB SBB006523, GW 9662
T226022978-25-2
GW9662 (TIMTEC-BB SBB006523) is a specific PPARγ antagonist (IC50: 3.3 nM, in a cell-free assay), with 100 to 1000-fold functional selectivity for PPARγ than PPARα δ in cells.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Quizartinib
AC220
T2066950769-58-1
Quizartinib (AC220) is an inhibitor of FLT3 (Kd: 1.6 nM) and demonstrates high selectivity for FLT3 when tested against a panel of 227 additional kinases.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Torin 1
T60451222998-36-8
Torin 1 is an effective inhibitor of mTORC1 2 with (IC50: 2 nM 10 nM); has 1000-fold selectivity for mTOR than PI3K.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
TPN171
T131931229018-87-4In house
TPN171 is potent PDE5 inhibitor with subnanomolar potency for PDE5 and good selectivity over PDE6, which has the potential for the treatment of pulmonary arterial hypertension (PAH). TPN171 was proven to exert a longer lasting effect than sildenafil in animal models, providing a foundation for a once-daily oral administration for its clinical use.
  • Inquiry Price
8-10weeks
Size
QTY
TargetMol | Inhibitor Hot
VER-155008
VER155008
T70101134156-31-2
VER-155008 is a potent Hsp70 family inhibitor with IC50 of 0.5 μM, 2.6 μM, and 2.6 μM in cell-free assays for HSP70, HSC70, and GRP78, respectively, >100-fold selectivity over HSP90.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Ro-3306
T2356872573-93-8
RO-3306 is a selectivity ATP-competitive CDK1 inhibitor (Ki: 20 nM). The selectivity of RO-3306 for CDK1 is >15-fold higher than a diverse panel of human kinases.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
G-418 disulfate
Geneticin sulfate, Geneticin, G418 Sulfate, Antibiotic G-418 sulfate
T6512108321-42-2
G-418 disulfate (Geneticin sulfate) is an aminoglycoside antibiotic that selectively inhibits eukaryotic protein synthesis by blocking peptide chain elongation.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Adezmapimod
SB203580, RWJ 64809, PB 203580
T1764152121-47-6
Adezmapimod (SB 203580) is a selective, ATP-competitive p38 MAPK inhibitor (IC50=0.3-0.5 μM) that activates autophagy and mitochondrial autophagy, with more than 100-fold higher selectivity over PKB, LCK, and GSK-3β.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
T0070907
T6689313516-66-4
T0070907(IC50=1 nM) , an effective and specific PPARγ inhibitor, with the >800-fold selectivity over PPARα and PPARδ.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
BAY-876
T37131799753-84-6In house
BAY-876 is an orally active, selective inhibitor of glucose transporter 1 (GLUT1, IC50= 2 nM), exhibiting over 130-fold greater selectivity for GLUT1 than GLUT2, GLUT3, and GLUT4. It also inhibits glycolytic metabolism and ovarian cancer growth.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
C-176
STING inhibitor 1, C176
T5154314054-00-7
C-176 (STING inhibitor 1) is a STING inhibitor with selectivity and blood-brain barrier permeability. C-176 inhibits STING-mediated IFNβ production and possesses anti-inflammatory activity.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Ritobegron HCl
Ritobegron hydrochloride, KUC-7483, KUC7483, KUC 7483
T34333476333-91-2In house
Ritobegron (KUC-7483), an effective and selective β3-adrenergic receptor agonist, shows effective β(3)-AR agonist activity on transfected human β-AR and has an effect on the bladder of rats Shows high selectivity with other organs.
  • Inquiry Price
3-6 months
Size
QTY
EGFR-IN-1 hydrochloride
T11157L2227455-78-7In house
EGFR-IN-1 hydrochloride is an irreversible and specific inhibitor of L858R T790M mutant EGFR, with 100-fold selectivity over wild-type EGFR. It exhibits potent antitumor and antiproliferative activity in H1975 cells and mutant HCC827 cells with IC50s of 4 and 28 nM, respectively.
  • Inquiry Price
8-10weeks
Size
QTY
TargetMol
RMM-46
RMM46
T261031307896-46-3In house
RMM-46 is a reversible covalent inhibitor with high ligand efficiency and selectivity for MSK RSK family kinases.
  • Inquiry Price
6-8 weeks
Size
QTY
TargetMol | Citations Cited
ZLD1039
ZLD-1039, ZLD 1039
T292311826865-46-6In house
ZLD1039 is a potent, orally bioavailable EZH2 (Enhancer of Zeste Homolog 2) inhibitor with high selectivity. It demonstrates strong, concentration-dependent inhibition of both wild-type and mutant (Y641F and A677G) PRC2 (Polycomb Repressive Complex 2) enzymatic activities, exhibiting IC50 values of 5.6, 15, and 4.0 nM, respectively. Additionally, ZLD1039 effectively suppresses breast tumor growth and metastasis.
  • Inquiry Price
6-8 weeks
Size
QTY
gsk040
T634182752331-09-0In house
GSK040, a potent and highly selective inhibitor of BET BD2, exhibits a pIC50 of 8.3, demonstrating over 5000-fold selectivity against BET BD1 (pIC50=4.6). This compound is primarily utilized in oncology and immunology research [1].This compound is unstable in powder form and other related salt forms are recommended.
  • Inquiry Price
3-6 months
Size
QTY